Mundipharma today announced completion of patient enrolment for the ongoing, global Phase III ReSPECT trial evaluating REZZAYO ® (rezafungin). The ReSPECT trial is a global, randomised, double-blind, ...

Bridging verified identity, real credit data, and real payments — a new standard for trusted digital retailing across dealer websites, campaigns, and marketplaces. FlexPath DXP, developer of the ...

Mantoverde (70%-owned by Capstone Copper and 30%-owned by Mitsubishi Materials Corporation) is an open-pit copper-gold mine located in the Atacama region of Chile. Since the 1990s, Mantoverde operated ...

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 ...